|
 | Dr. Scott A.M. ChambersDirector for Intellectual Property
Patton Boggs LLP 8484 Westpark Drive, Suite 900 McLEAN, VIRGINIA 22102 (Fairfax Co.)
Telephone: 703-744-8000 Fax: 703-744-8001 http://www.pattonboggs.com/schambers
|
Profile Visibility  | | #132 in weekly profile views out of 1,306 lawyers in McLEAN, VIRGINIA 22102 | | #60,152 in weekly profile views out of 968,464 total lawyers Overall |
|
What is This?
|
| |
| Practice Areas | Intellectual Property; Biotechnology; Hatch-Waxman; International Trade; Administrative Law | | | Education | George Washington University, J.D., magna cum laude, 1993, Ohio State University, B.S., 1974; Florida State University, Ph.D., 1981; Maxwell School of Citizenship and Public Affairs, Syracuse University, Cert. of Public Admin., 1999 | | | Admitted | 1993, Virginia; 1994, District of Columbia and U.S. Court of Appeals for the Federal Circuit; registered to practice before U.S. Patent and Trademark Office, 1994 | |
| Memberships | American Bar Association; Giles S. Rich American Inn of Court for Intellectual Property; National Association of Patent Practitioners; Biojudiciary Project; American Intellectual Property Law Association; American Chemical Society. | | | Born | Massillon, Ohio | | | Biography | Order of the Coif. Senior Staff Fellow, National Institutes of Health, 1986-1988. Recipient: William Brinks Olds Hofer Gilson & Lione Scholarship, Excellence in Intellectual Property Law, 1992; Silver Medal, U.S. Department of Commerce, 1999; Recognition Award, National Partnership for Reinventing Government, 1998; Special Achievement and Gainsharing Awards, United States Patent and Trademark Office, 1989-1992. Law Clerk to Judge Randal R. Radar, U.S. Court of Appeals for the Federal Circuit, 1993-1994. Author: "'Written Description' and Patent Examination Under the US Patent and Trademark Office Guidelines," 7 IP Litigator 9, 2001; Chambers, S.A., "Harmonization in Biotechnology Patent Practice," 18 Biotechnology Law Report 517 (1999); "Comments on the Patentability of Certain Inventions Associated with the Identification of Partial cDNA Sequences," 23 AIPLA Q.J. 53, 1995; "The Exhaustion Doctrine in Biotechnology," 35 IDEA 289, 1995. Co-Author: Englund, S.R., Chambers, S.A., and Leary, D.W., "Recent IP Legislation is Most Sweeping in Years," National Law Journal, Jan. 31, 2000 at C18; Kunin, S.G. and Chambers, S.A., "Intellectual Property: The Engine for Health Care Changes in the New Millennium," 5 Journal of Commercial Biotechnology 166, 1998; Linck, N.J. & Chambers, S.A., "Utility in Biotech Patent Applications," 13 Biotechnology 962, 1995. Speaker: The National Academies Committee on Intellectual Property Rights, Exploring Patenting and Licensing for Proteomics Workshop, 2004; "Federal Trade Commission Hearings on Competition and Intellectual Property Law and Policy in the Knowledge-Based Economy," Antitrust Division Roundtables, 2002; "Federal Trade Commission Hearings on Competition and Intellectual Property Law and Policy in the Knowledge-Based Economy," Foundational Issues in Patents and Antitrust, 2002; "Recent Cases Impacting the Biotechnology and Pharmaceutical Sectors in the United States," Second International Conference on Intellectual Property Rights and Biotechnology, Ministry of Economic Affairs, Republic of China (Taiwan), 2001; "Recent Developments in Biotechnology Practice in the United States," Second International Conference on Intellectual Property Rights and Biotechnology, Ministry of Economic Affairs, Republic of China (Taiwan), 2001; "United States Patent Practice for Biotechnological Inventions," Lecture Series to the Taiwanese Biotechnology Examiners and Judges, Ministry of Economic Affairs, Intellectual Property Office, Republic of China (Taiwan), 2001; "'Written Description' and Patent Examination—the U.S. Patent and Trademark Office Guidelines," American Bar Association Intellectual Property Law Spring CLE Program, Washington, D.C., 2000; "The Written Description Guidelines" (1999); New York, New York, "Technology Transfer: Patents, Licenses and Material Transfer Agreements—Too Much of a Good Thing? Or Not Enough?" and "The Business of Invention" (1998); and Houston, Texas, "The Impact of CAFC Decisions on Biotechnology Patent Practice," Biotechnology Industry Organization (BIO), Seattle, Washington, (1997); "Patent Protection for a World Economy," Canadian Ministry for Intellectual Property, Molecular Farming, London, Ontario, (1999); "Patenting Biotechnological Inventions," Industrial College of the Armed Forces, Washington, D.C., (1995-1999); "Patent Appeals Outside and Inside the Agency," Lucent Technologies Conference for Intellectual Property Attorneys, Murray Hill, New Jersey, (1999); "Recent Federal Circuit Opinions Affecting Biotechnology," Washington and the West Seminar, Los Angeles, California, 1999. Featured Speaker: "Intellectual Property Law and TRIPS Compliance," Commercial Law Development Division of the Department of Commerce, Cairo, Egypt, to the Egyptian Judiciary and Government, 2003; Commercial Law Development Division of the Department of Commerce, Cairo and Luxor, Egypt, to the Egyptian Judiciary on Patents and Intellectual Property Law, 2000. Media Panelist, "The Road Betond Proteomics," Drug Discovery Technology 2001, Boston, Massachusetts, 2001. Distinguished Graduate, Police Academy, 1990. Participant, Chair of Government-Academic Partnerships: Bioethics and Genome Research, Federation of American Societies for Experimental Biology, Washington, D.C., 2001. Member: Editorial Board, Biotechnology Law Report; Advisory Board, Patent, Trademark and Copyright Journal. | | | Reported Cases | Abbott Laboratories v. Novapharm, Ltd., 323 F.3d 1324 (Fed. Cir. 2003); Emergency Fuel, LLC v. Pennzoil-Quaker State Co., 71 Fed. Appx. 826 (Fed. Cir. 2003); In re Dance, 160 F.3d 1339 (Fed. Cir. 1998); In re Clement, 131 F.3d 1464 (Fed. Cir. 1997); In re Emert, 124 F.3d 1458 (Fed. Cir. 1997); Hoechst-Roussel Pharmaceuticals, Inc. v. Lehman, 109 F.3d 756 (Fed. Cir. 1997); In re Mayne, 104 F.3d 1339 (Fed. Cir. 1997); Merck & Co., Inc. v. Kessler, 80 F.3d 1543 (Fed. Cir. 1996); In re Alton, 76 F.3d 1168 (Fed. Cir. 1996); Honingsbaum v. Lehman, 903 F. Supp. 8 (D.D.C. 1995) | | | ISLN | 900121478 | |
|
|